跳至主要内容
临床试验/EUCTR2010-024428-10-FR
EUCTR2010-024428-10-FR进行中(未招募)1 期

Traitement des épidermolyses bulleuses simples de type Dowling Maera par l'érythromicine orale

CHU de NICE0 个研究点目标入组 8 人开始时间: 2011年2月3日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
CHU de NICE
入组人数
8

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Patient of 2 sexes
  • - Carrier of a severe EBS-DM (more than 2 new bubbles a day on average)
  • - Age from 3 months to 8 years. From this age we consider that the patient will less need this treatment or can take cyclines.
  • - Systematic Obtaining of the consent by the parents of the child, after information about the objectives and the constraints of the study.
  • - Agreement of the minor
  • - Patient member to the Social Security
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Patient allergic to the érythromycine
  • - Patient presenting an intolerance to the fructose, a syndrome of bad absorption some glucose and some galactose or a deficit it sucrase-isomaltase
  • - Renal and\or hepatic insufficiency
  • - Patient taking a medicine against indicated or disadvised in association with the erythromycin

研究者

发起方
CHU de NICE

相似试验